Delivery Order SPE2DB24D9120-SPE2DB24FVWJ4

Award Date 9/12/24
Potential Completion Date 10/3/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,690.47 contract is for the delivery of 4566087878 units of the YF-VAX 1 dose vaccine, with an ultimate completion date of October 31, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,670.13, is for the delivery of 4,567,939,520 units of the YF-VAX 1 dose vaccine. The contract has an ultimate completion date of May 1, 2025 and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,772.79 contract is for the delivery of 4,564,374,023 units of the YF-VAX 1 dose vaccine and has an ultimate completion date of April 24, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,126.98, is for the delivery of 4,565,563,472 doses of the YF-VAX 1 DOSE VIALS vaccine. The order has a completion date of September 12, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,384,300 units of the YF-VAX 1 dose vaccine. The contract has a ceiling value of $1,113.42 and an ultimate completion date of June 13, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,507.92 contract is for the delivery of 4565890426 units of the YF-VAX 1 dose vaccine vials by October 4, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,772.79 firm fixed-price contract is to provide 4,566,637,211 units of the YF-VAX 1 dose vaccine to the DLA, with a period of performance through December 9, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,833.29 contract is for the delivery of YF-VAX 1 dose vials, a specialized pharmaceutical product, with a completion date of November 26, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,512,925 doses of the YF-VAX vaccine, with a ceiling value of $11,269.80 and a completion date of December 10, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,690.47, is for the delivery of 4565545219 units of the YF-VAX 1 dose vaccine. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a ceiling value of up to...
  • SPE2DB24D9120
    Indefinite Delivery Contract
  • SPE2DB24D9120-SPE2DB24FVWJ4
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,269.80 contract is for the delivery of 4,565,860,548 units of the YF-VAX 1 dose vaccine, with a completion date of October 3, 2024.

DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military healthcare facilities worldwide. This award is not subject to any set-aside designation and is part of the company's broader role as a prime vendor for pharmaceutical products and pharmacy services to the Department of Defense.

Generated 12/12/24, 10:08 AM